Suchergebnisse - "Li, Yanying"

PubPharm (6)

1

Real-world clinical analysis in 190 advanced NSCLC patients with uncommon EGFR mutations : A multi-center study

enthalten in: Cancer science | 2023

von Qin, Y. | Long, Y. | Tang, Y. | +15

2

A phase I study of the tyrosine kinase inhibitor anlotinib combined with platinum/pemetrexed-based chemotherapy in untreated nonsquamous non-small-cell lung cancer

enthalten in: Investigational new drugs | 2022

von Huang, M. | Liu, Y. | Yu, M. | +5

3

Distribution and therapeutic outcomes of intergenic sequence-ALK fusion and coexisting ALK fusions in lung adenocarcinoma patients

enthalten in: Lung cancer (Amsterdam, Netherlands) | 2021

von Cai, C. | Tang, Y. | Li, Y. | +11

4

Durable complete response after afatinib and crizotinib in an advanced non-small cell lung cancer patient with EGFR L861Q mutation and acquired MET amplification : a case report

enthalten in: Annals of palliative medicine | 2020

von Long, Y. | Zhang, K. | Li, Y. | +3

5

Progression of Central Nervous System Metastases in Advanced Nonsmall Cell Lung Cancer Patients Effectively Treated with First-Generation Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor

enthalten in: Cancer biotherapy & radiopharmaceuticals | 2018

von Yu, M. | Zhao, Q. | Li, Y. | +12

6

Efficacy of epidermal growth factor receptor-tyrosine kinase inhibitors for lung squamous carcinomas harboring EGFR mutation : A multicenter study and pooled analysis of published reports

enthalten in: Oncotarget | 2017

von Liu, Y. | Zhang, Y. | Zhang, L. | +15

1
[1]